Search

Your search keyword '"Corea F"' showing total 244 results

Search Constraints

Start Over You searched for: Author "Corea F" Remove constraint Author: "Corea F"
244 results on '"Corea F"'

Search Results

1. Do patients’ and referral centers’ characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

2. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

3. Renal tumor heterogeneity in sporadic and inherited renal cancer: a translational multimodal approach

5. Data monitoring roadmap. The experience of the Italian Multiple Sclerosis and Related Disorders Register

6. Estimated GFR and the Effect of Intensive Blood Pressure Lowering After Acute Intracerebral Hemorrhage

8. Signs and symptoms of COVID-19 in patients with multiple sclerosis

9. A principle-based approach to AI: the case for European Union and Italy

10. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

11. Risk of multiple sclerosis relapses when switching from fingolimod to cell-depleting agents: the role of washout duration

12. The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis

13. Do patients' and referral centers' characteristics influence multiple sclerosis phenotypes? Results from the Italian multiple sclerosis and related disorders register

14. Signs and symptoms of COVID-19 in patients with multiple sclerosis

15. SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study

16. Oral anticoagulants in the oldest old with recent stroke and atrial fibrillation

17. Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation

18. The Italian multiple sclerosis register

19. Disease modifying therapies and Covid‐19 severity in Multiple Sclerosis

20. Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention

21. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis

22. Safety of Anticoagulation in Patients Treated with Urgent Reperfusion for Ischemic Stroke Related to Atrial Fibrillation

23. Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes

24. Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register

27. Recommendations on telestroke in Europe

32. Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin?

33. Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke

35. Effectiveness of Natalizumab on Multiple Sclerosis patients: the Italian registry experience

36. Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study

43. Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes

44. Intensive blood pressure reduction with intravenous thrombolysis therapy for acute ischaemic stroke (ENCHANTED): an international, randomised, open-label, blinded-endpoint, phase 3 trial

45. Trattamento riabilitativo e continuità dell'assistenza

46. Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients with Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study

47. Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study

48. Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: results from the RAF-study (Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation)

49. Prestroke CHA2DS2-VASc Score and Severity of Acute Stroke in Patients with Atrial Fibrillation: Findings from RAF Study

50. Sex-related differences in risk factors, type of treatment received and outcomes in patients with atrial fibrillation and acute stroke: Results from the RAF-study (Early Recurrence and Cerebral Bleeding in Patients with Acute Ischemic Stroke and Atrial Fibrillation)

Catalog

Books, media, physical & digital resources